Abstract:Importance: Generating robust and timely evidence about the respiratory health risks of electronic cigarettes (e-cigarettes) is critical for informing state and federal regulatory standards for product safety. Objective: To examine the association of e-cigarette use with incident respiratory conditions, including chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, and asthma. Design, setting, and participants: This prospective cohort study used data from the nationally representative cohort of US adults from the Population Assessment of Tobacco and Health (PATH) study, including wave 1 from 2013 to 2014, wave 2 from 2014 to 2015, wave 3 from 2015 to 2016, and wave 4 from 2016 to 2018. Individuals aged 18 years and older at baseline with no prevalent respiratory conditions were included in the analyses. Analyses were conducted from February to July 2020. Exposures: e-Cigarette use was assessed by self-reported current use status (never, former, or current) at baseline. Main outcomes and measures: Incident respiratory conditions, including COPD, emphysema, chronic bronchitis, and asthma, as well as a composite respiratory disease encompassing all 4 conditions. Results: Among 21 618 respondents included in the analyses, 11 017 (491%) were men and 12 969 (65.2%) were non-Hispanic White. A total of 14 213 respondents were never e-cigarette users, 5076 respondents (11.6%) were former e-cigarette users, and 2329 respondents (5.2%) were current e-cigarette users. Adjusted for cigarette and other combustible tobacco product use, demographic characteristics, and chronic health conditions, there was an increased risk of respiratory disease among former e-cigarette uses (incidence rate ratio [IRR], 1.28; 95% CI, 1.09-1.50) and current e-cigarette users (IRR, 1.31; 95% CI, 1.08-1.59). Among respondents with good self-rated health, the IRR for former e-cigarette users was 1.21 (95%CI, 1.00-1.46) and the IRR for current e-cigarette users was 1.43 (95% CI, 1.14-1.79). For specific respiratory diseases among current e-cigarette users, the IRR was 1.33 (95% CI, 1.06-1.67) for chronic bronchitis, 1.69 (95% CI, 1.15-2.49) for emphysema, 1.57 (95% CI, 1.15-2.13) for COPD, and 1.31 (95% CI, 1.01-1.71) for asthma. Conclusions and relevance: This cohort study found that e-cigarette use was associated with an increased risk of developing respiratory disease independent of cigarette smoking. These findings add important evidence on the risk profile of novel tobacco products.

E-cigarette use and subsequent asthma outcomes in patients with current asthma: Findings from the National Asthma Survey

Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018

E-cigarette use and respiratory illnesses among U.S. adults: An analysis of the Population Assessment of Tobacco and Health Study

Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal

Association between e-cigarette use and susceptibility to tobacco product use: findings from the 2019 China National Youth Tobacco Survey

Use of E-Cigarettes and Self-Reported Lung Disease Among US Adults

Associations for subgroups of E-cigarette, cigarette, and cannabis use with asthma in a population sample of California adolescents

E-Cigarette-Associated Acute Severe Asthma in a Smoking-Naïve Adolescent: A Case Report

Long-Term Impact of Daily E-cigarette Exposure on the Lungs of Asthmatic Mice

Effect of E-Cigarette aerosol exposure on airway inflammation in a murine model of asthma

E-cigarette use or dual use of E-cigarette and combustible cigarette and mental health and cognitive impairment: Findings from the National Health Interview Survey, 2020–2021

The Effects of Electronic Cigarette Use Patterns on Health-Related Symptom Burden and Quality of Life: Analysis of US Prospective Longitudinal Cohort Study Data

Questionable Effects of Electronic Cigarette Use on Cardiovascular Diseases From the National Health Interview Survey (NHIS, 2014-2021)

E-cigarette use and associated factors among adults aged 18-44 years in China: Findings from an online survey

Rates of adverse events and related risk factors following e-cigarette use

Electronic cigarette use and chest pain in US adults: Evidence from the PATH study

Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma

Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes

Association between electronic cigarettes use and whole blood cell among adults in the USA—a cross-sectional study of National Health and Nutrition Examination Survey analysis

Health outcomes of electronic cigarettes

Electronic cigarette use in relation to changes in smoking status and respiratory symptoms